Search
Ligand Pharmaceuticals Inc
LGNDAdd to Watchlist
322.750USD
+5.420+1.71%
Close 10-30 16:00（ET）
6.44BMarket Cap
42.04P/E TTM
Today
+1.71%
5 Days
+6.33%
1 Month
+3.32%
6 Months
+40.66%
Year to Date
+70.70%
1 Year
+68.71%
Key Figures
319.220Open
324.900High
7.08KVolume
42.04P/E TTM
25.23P/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
317.330Prev. Close
314.505Low
2.27MTurnover
LossP/E Static
6.65P/B
0.00%Div Yield TTM
12.60%ROA
326.63052wk High
0.03Volume Ratio
-4.03MNet Profit
19.94MShares
7.6734EPS TTM
1.23Beta
17.13%ROE
175.89052wk Low
4.81%Amplitude
91.37%Gross Margin
6.44BMarket Cap
0.11Reward/Risk
2.34%Risk Rate
Ligand Pharmaceuticals Inc's Score
-0.09vs previous score
Forecast8.91
Financial Health8.96
Technical3.75
Valuation Dimensions6.68
Institutional Confidence10.00
Risk Assessment8.18
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Ligand Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Ligand Pharmaceuticals Inc Latest Earnings Call Transcripts
Ligand (LGND) Q3 2026 Earnings Call: Royalty Revenue Rises 51%, EPS Guidance Raised
Ligand’s Q3 2026 earnings call covered 51% royalty revenue growth, Filspari momentum, the XOMA portfolio and higher adjusted EPS guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-1.43/2.38
Revenue / Forecast
149.03M/77.23M
Ligand Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolLGND
Number of employees68
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 13.37% |
| Vanguard Portfolio Management, LLC | 5.49% |
| Janus Henderson Investors | 4.97% |
| Vanguard Capital Management, LLC | 4.23% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 58.25% |
| Investment Advisor/Hedge Fund | 39.07% |
| Research Firm | 3.67% |
| Individual Investor | 2.39% |
Related Instruments
+3.19%
-0.73%
+1.41%
+2.18%
-0.19%
+7.02%
+1.15%
+3.06%
+2.20%
+1.90%
+3.50%
+1.78%
+1.40%
+2.81%
+1.71%
+13.33%
-0.47%
+4.50%
-0.24%
-0.55%Popular Instruments
51788.900
-548.500 (-1.05%)
28406.600
-658.400 (-2.27%)
7583.100
-92.600 (-1.21%)
12785.000
-56.000 (-0.44%)
62328.000
-1656.000 (-2.59%)
6120.900
-77.700 (-1.25%)
102.428
+0.026 (+0.03%)
344.630
-4.280 (-1.23%)
204.640
-9.020 (-4.22%)
3874.710
-146.240 (-3.64%)
FAQs
What is the current price of Ligand Pharmaceuticals Inc (LGND)?
The current price of Ligand Pharmaceuticals Inc (LGND) is 322.75.
What is the symbol of Ligand Pharmaceuticals Inc?
The ticker symbol of Ligand Pharmaceuticals Inc is LGND.
What is the 52-week high of Ligand Pharmaceuticals Inc?
The 52-week high of Ligand Pharmaceuticals Inc is 326.63.
What is the 52-week low of Ligand Pharmaceuticals Inc?
The 52-week low of Ligand Pharmaceuticals Inc is 175.89.
What is the market capitalization of Ligand Pharmaceuticals Inc?
The market capitalization of Ligand Pharmaceuticals Inc is 6.44B.
Is Ligand Pharmaceuticals Inc (LGND) currently rated as Buy, Hold, or Sell?
According to analysts, Ligand Pharmaceuticals Inc (LGND) has an overall rating of Buy, with a price target of 345.75.
What is the Earnings Per Share (EPS TTM) of Ligand Pharmaceuticals Inc (LGND)?
The Earnings Per Share (EPS TTM) of Ligand Pharmaceuticals Inc (LGND) is 7.67.